TrialJournal of clinical laboratory analysis2000

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia.

L A Salazar et al.PubMed ↗Full text ↗

No numbers read from the abstract.